The type III intermediate filament protein glial fibrillary acidic protein (GFAP) contributes to the homeostasis of astrocytes, where it co-polymerizes with vimentin. Conversely, alterations in GFAP assembly or degradation cause intracellular aggregates linked to astrocyte dysfunction and neurological disease. Moreover, injury and inflammation elicit extensive GFAP organization and expression changes, which underline reactive gliosis. Here we have studied GFAP as a target for modification by electrophilic inflammatory mediators. We show that the GFAP cysteine, C294, is targeted by lipoxidation by cyclopentenone prostaglandins (cyPG) in vitro and in cells. Electrophilic modification of GFAP in cells leads to a striking filament rearrangement, with retraction from the cell periphery and juxtanuclear condensation in thick bundles. Importantly, the C294S mutant is resistant to cyPG addition and filament disruption, thus highlighting the critical role of this residue as a sensor of oxidative damage. However, GFAP C294S shows defective or delayed network formation in GFAP-deficient cells, including SW13/cl.2 cells and GFAP-and vimentin-deficient primary astrocytes. Moreover, GFAP C294S does not effectively integrate with and even disrupts vimentin filaments in the short-term. Interestingly, short-spacer bifunctional cysteine crosslinking produces GFAP-vimentin heterodimers, suggesting that a certain proportion of cysteine residues from both proteins are spatially close. Collectively, these results support that the conserved cysteine residue in type III intermediate filament proteins serves as an electrophilic stress sensor and structural element. Therefore, oxidative modifications of this cysteine could contribute to GFAP disruption or aggregation in pathological situations associated with oxidative or electrophilic stress.
Introduction
GFAP, along with vimentin, desmin and peripherin constitute the type III class of intermediate filament proteins, which are expressed in a cell type-dependent manner. In astrocytes, GFAP is an important component of the cytoplasmic intermediate filament network and plays a key role in physiology and in pathophysiology. Astrocytes are considered functional integrators as well as neurogenic precursors in the central nervous system [1] . Being a main cytoskeletal component, it is generally accepted that GFAP plays an architectural role maintaining the mechanical resistance and shape of astrocytes [2] . However, studies in mice engineered to alter or ablate the expression of GFAP alone or of GFAP and vimentin, a polymerization partner for GFAP in astrocytes, indicate that these intermediate filaments are also important for astrocyte homeostasis. Thus, roles of GFAP in astrocyte motility, proliferation and interaction with neurons have been proposed. [2] [3] [4] . Importantly, GFAP appears to play a dual role in central nervous system injury [3] . In the acute stage, the presence of GFAP and vimentin plays a protective role, as deduced from slower healing [5] and more prominent loss of neuronal synapses [6] in neurotrauma or the larger infarct size after ischemic stroke [7] in mice deficient for both GFAP and vimentin (GFAP -/-Vim -/-). However, at later stages, GFAP neurological disorder associated with defective intermediate filament degradation [10] [11] [12] . Injury of the central nervous system is accompanied by the release of reactive mediators, including oxidant species and electrophilic lipids. The roles of these species may also be double-sided and depend on their levels, time of release, and context factors. The cyclopentenone prostaglandins (cyPG) are reactive endogenous mediators generated by dehydration of prostaglandins [13, 14] . They can exert both beneficial and detrimental effects that have been extensively studied, and occur mostly through their ability to covalently modify proteins, predominantly at specific cysteine residues [15] through Michael addition. In the central nervous system, increased levels of the cyPG 15-deoxy-Δ 12,14 -PGJ 2 (15d-PGJ 2 ) have been found to correlate with good outcome in atherothrombotic stroke [16] , and both 15d-PGJ 2 and PGA 1 have been reported to exert neuroprotection [17] [18] [19] and suppress the activation of microglia [20] . Nevertheless, there is also abundant evidence on deleterious effects exerted by cyPG, in particular, PG of the J series. PGJ 2 has been reported to increase in rodents upon stroke and traumatic brain injury and to induce neurotoxic effects [21] , including neuronal apoptosis [22, 23] . In fact, J-series PG can inhibit protein degradation through various mechanisms, including modification of ubiquitin hydrolases and several components of the proteasome [24] [25] [26] . This contributes to protein aggregation, a pathogenic feature of many neurodegenerative diseases, for which J-series cyPG have been used as pharmacological models for Alzheimer's disease [21] . Importantly, in addition to their role in central nervous system pathophysiology, cyPG have been used as probes for the identification of proteins with cysteine residues especially prone to modification by oxidative or electrophilic species and therefore, playing a role in thiolmediated signal transduction and/or in the pathophysiology of diseases associated with oxidative stress. GFAP and the other type-III intermediate filament proteins (vimentin, desmin and peripherin) share common structural features. Their monomers consist of head, rod and tail domains. Head and tail domains do not have a defined structure, whereas the rod domain contains four main alpha-helical segments joined by linkers. Monomers dimerize to form parallel dimers and two dimers associate in an antiparallel manner to form tetramers. Eight apposed tetramers are believed to constitute a basic unit or "unit-length filament" (ULF), which in turn join together to form non polar filaments that are highly dynamic [27] . All type III intermediate filament proteins possess a conserved cysteine residue, C294 in GFAP. In vimentin, the equivalent cysteine residue (C328) is the target for modification by various endogenous and exogenous oxidants and electrophiles [28, 29] , and plays an important role in the dynamics of vimentin network in response to electrophilic and oxidative stress [30] .
In a previous proteomic study on cyPG targets GFAP appeared as a putative target for biotinylated PGA 1 in murine fibroblasts [31] . Here we have characterized the modification of GFAP by various electrophilic compounds and oxidants and explored the functional implications of these modifications. Moreover, we have assessed the role of the C294 in network formation. Our results show that this cysteine residue is a sensitive sensor for oxidative and electrophilic stress. Importantly, this single residue is required for appropriate GFAP self-oligomerization and co-polymerization with vimentin, its partner in mature astrocytes. These results point to a structural requirement and a general mechanism for redox sensing in type III intermediate filaments involving the conserved cysteine residue.
Materials and methods

Reagents
Purified bovine GFAP was from Progen. Purified human GFAP was from Millipore. Syrian hamster vimentin was from Cytoskeleton. 9,10-dihydro-Δ 12,14 -15d-PGJ 2 and cyPG, including PGA 1 and 15-deoxy-Δ 12,14 -PGJ 2 (15d-PGJ 2 ) and their biotinylated analogs were from Cayman Chemical. Phalloidin-Alexa568 was from GE Healthcare. Antibodies used were anti-GFAP from DAKO, anti-vimentin V9 from Santa Cruz Biotechnology (sc-6260) and Alexa-488, 568 or 647-conjugated secondary antibodies from Molecular Probes. Dithiothreitol (DTT) was from Invitrogen. Dibromobimane (DBB) and 4,6-diamidino-2-phenylindole (DAPI) were from Sigma.
In vitro modification of GFAP by electrophiles
Both, the human and bovine proteins supplied lyophilized in 8 M urea were reconstituted in 5 mM Tris pH 7.4 to a final concentration of 1 mg/ml and dialyzed in a step-wise manner against 4, 2 and 0 M urea in 5 mM Tris pH 7.4, 0.1 mM DTT and 0.32 mg/ml Pefablock at 10°C (buffer A). The dialyzed proteins were centrifuged at 200,000g for 15 min at 4°C, discarding the pellet. Protein concentration was measured as the absorbance at 280 nm, using Nanodrop, with an extinction coefficient of 20,100 M −1 cm −1 [32] . To assess cyPG addition, GFAP at 5 μM in buffer A was incubated with the indicated concentrations of biotinylated cyPG for 2 h at r.t. Competition with non-biotinylated cyPG was carried out by including the corresponding PG at 100 μM in the incubation mixture. For blocking the cysteine residue, the protein was pre-incubated for 30 min in the dark in the presence of 10 mM iodoacetamide. Incorporation of biotinylated cyPG into GFAP was assessed by SDS-PAGE and blot with HRP-streptavidin, as previously described [33] . To ensure even loading and transfer, GFAP was detected by western blot.
SDS-PAGE and western blot
Aliquots from in vitro incubation mixtures of recombinant GFAP and/or vimentin containing between 2 and 4 μg of protein, or of cell lysates containing 30 μg of protein were denatured with Laemmli buffer for 5 min at 95°C. Samples were loaded onto 7.5% polyacrylamide gels for crosslinking assays or 10% polyacrylamide gels for analysis of protein levels in cell lysates. All samples were analyzed under reducing conditions. After electrophoresis, proteins were transferred to Immobilon-P membranes (Millipore) using a Tris-glycine methanol three-buffer system, as recommended by the manufacturer, on a semidry transfer unit (Transblot) from Bio-Rad, using a constant voltage (22 V) for 50 min. Membranes were blocked with 2% (w/v) low-fat powdered milk in T-TBS (20 mM Tris-HCl pH 7.5, 500 mM NaCl, 0.05% (v/ v) Tween-20). Subsequently, membranes were incubated with primary antibodies at 1:500 dilution in 1% bovine serum albumin in T-TBS, and horseradish peroxidase-conjugated secondary antibodies (Dako) at 1:2000 dilution in the same solution. Membrane washes were performed with T-TBS. Proteins of interest were detected with the ECL system from GE Healthcare and exposure of membranes to Agfa photographic film.
GFAP polymerization and crosslinking
For polymerization, GFAP at 3.8 μM in 5 mM Tris-HCl pH 7.4, 0.1 mM DTT was incubated with 150 mM NaCl for 15 min at 37°C. Cysteine crosslinking was performed by incubation of the protein with the bifunctional agent DBB at 20 μM for 1 h at 37°C. For heteropolymerization with vimentin, 2 µM of each protein was incubated as above. In some assays, the mixture was preincubated with 150 mM NaCl for 30 min at 37°C. Subsequent crosslinking was achieved by incubation in the presence 20 μM DBB for 1 h at 37°C.
Cell culture and treatments
SW13/cl.2 cells were the generous gift of Dr. A. Sarria (University of Zaragoza, Spain) [34] . The U-373 MG glioblastoma astrocytoma cell line was from the American Type Culture Collection (ATCC). Cells were cultured in DMEM containing 10% fetal bovine serum (Sigma) plus antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin). The stable cell lines SW13 RFP//vimentin wt and RFP//vimentin C328S have been previously described [30] . Primary mouse cortical astrocytes from wild type mice or from mice deficient in GFAP and vimentin, "GV astrocytes" were obtained and cultured as previously described [9] . All the animal experiments were conducted according to protocols approved by the Ethics Committee of the University of Gothenburg (Dnr. 247-2014). Cells were treated with the indicated agents dissolved in DMSO or with an equivalent volume of DMSO in serum-free medium. Cells were lysed in 20 mM Tris-HCl, pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 0.1 mM β-mercaptoethanol, containing 0.5% SDS, 0.1 mM sodium orthovanadate and protease inhibitors (2 μg/ml each of leupeptin, aprotinin and trypsin inhibitor, and 1.3 mM Pefablock).
Pull-down of biotinylated proteins on neutravidin beads
Cell lysates from U-373 MG astrocytoma cells treated with vehicle or biotinylated 15d-PGJ 2 were diluted with lysis buffer containing 1% NP-40 instead of SDS in order to reduce the final SDS concentration to 0.1%. Aliquots containing 50 μg of protein were applied onto 50 µl of Neutravidin agarose beads (Pierce), equilibrated with 20 mM Tris pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 0.1% SDS, 1% NP-40 (buffer B). The lysate-resin slurry was incubated batch-wise for 2 h at 4°C. Beads were repeatedly washed with equilibration buffer by centrifugation at 2500g for 2 min at 4°C, after which, proteins bound to the resin were eluted by boiling in Laemmli buffer. Samples of the total lysate and the pull-down products were separated by SDS-PAGE. The presence of the proteins of interest in the avidin-bound fraction was assessed by western blot, as described [35] .
Immunoprecipitation
For immunoprecipitation of GFP-GFAP constructs, cell lysates were processed as above and aliquots containing 150 μg of protein were incubated with "GFP-trap" beads (Chromotek) for 1 h at 4°C. Beads were repeatedly washed with buffer B by centrifugation at 2500g for 2 min at 4°C, and retained proteins were eluted as above. Samples of the total lysates and GFP-trap-retained products were separated by SDS-PAGE and proteins of interest were detected by western blot. For immunoprecipitation of vimentin, aliquots of cell lysates containing 100 µg of protein were incubated overnight at 4°C with agarose-conjugated anti-vimentin V9 antibody (Santa Cruz Biotechnology SC-6260) in a final volume of 500 µl of lysis buffer containing 1% NP-40. Beads were washed several times with PBS by centrifugation at 14,000g for 1 min at 4°C. Samples of the total lysates and the immunoprecipitated products, eluted as above, were separated by SDS-PAGE.
Plasmids and transfections
Bicistronic plasmids for the expression of wild type or C328S human vimentin and RFP as separate products (RFP//vimentin wt and RFP// vimentin C328S) have been previously described [30] . A plasmid coding human GFAP (pCMV6-XL6 -GFAP, accession number: NM_ 002055) was obtained from Origene. GFP-GFAP was from Genecopoeia. The bicistronic expression vector RFP//GFAP was obtained by subcloning human GFAP into the EcoRI and SacII sites of pIRES2 DsRed-Express2 (Clontech). Cells were transfected with Lipofectamine2000 (Invitrogen) following the instructions of the manufacturer. The C294S and C294A mutants of these vectors were obtained by site directed mutagenesis using oligonucleotides: 5′-GCAGTCCTTGACCAG CGACCTGGAGTCTCTGC-3′ and 5′-GCAGTCCTTGACCGCCGACCTGGA GTCTCTGC-3′, respectively, with their corresponding complementary reverse oligonucleotides and the Quickchange XL kit (Agilent), following the manufacturer indications. All constructs were confirmed by sequencing (Secugen S.A., Madrid, Spain). For stable transfections cells were cultured in the presence of 500 μg/ml Geneticin (G418, Invitrogen).
Confocal microscopy
For confocal fluorescence microscopy cells were grown on glassbottom cell culture dishes (Mattek Corporation) and visualized on Leica SP2 or SP5 microscopes. Images were acquired every 0.5 µm and total projections or single sections are shown, as indicated.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked with 1% BSA (w/v) in PBS and incubated either with primary and secondary antibodies or with the fluorescent conjugate, anti-vimentin-Alexa 488. All the procedure was carried out at r.t. All antibodies were used at 1:200 dilution in 1% BSA in PBS, except anti-GFAP, which was used at 1:1000 dilution. Filamentous actin staining was achieved by incubation with Alexa-568 Phalloidin at 4 U/ ml in 1% BSA in PBS for 30 min. Nuclei were counterstained with DAPI at 3 μg/ml in PBS for 15 min.
Statistical analysis
For statistical analysis of results from in vitro assays, the two tailed unpaired Student's t-test was used. For comparison of multiple data sets the one-way analysis of variance followed by Tukey's post-test was used. In particular, this analysis was used for comparison of the effect of different electrophiles on the levels of GFAP in cell lysates of U373MG astrocytoma cells and primary astrocytes from wild type mice, as well as of their effect on GFAP distribution. All statistical analyses were carried out using GraphPad Prism 5.
Results
Modification of GFAP in vitro by electrophilic prostaglandins
The modification of GFAP by reactive mediators was first assessed by in vitro assays. Biotinylated analogs of cyPG (PGA 1 -B and 15d-PGJ 2 -B), the structure of which is shown in Fig. 1A , have been extensively used as probes for protein lipoxidation [14, 36] . We observed that biotinylated cyPG formed adducts with GFAP purified from human brain that were resistant under denaturing conditions, as indicated by the concentration-dependent increase in the biotin signal associated to the protein detected after SDS-PAGE and blot (Fig. 1B) . Nevertheless, in this protein preparation, several bands were detected, which were biotin and GFAP-positive. These bands were found to correspond to human GFAPα by peptide fingerprint (accession number in UniprotKB P14136), thus they potentially represent degradation products. Therefore, to obtain more homogeneous results we employed purified bovine GFAP, which is 95% identical to the human protein. This protein preparation gave a single band in SDS-PAGE and confirmed the incorporation of biotinylated cyPG (Fig. 1C) . Interestingly, modification by biotinylated cyPG was significantly reduced in the presence of an excess of the parent PG, suggesting that they may compete for the same site(s) on the protein (Fig. 1D) . Moreover, biotinylated cyPG incorporation was virtually blocked by iodoacetamide (Fig. 1E ), which indicates that binding takes place at the cysteine residue. Thus, these results show that GFAP is a target for modification by cyPG in vitro.
Lipoxidation of GFAP in cells
We next explored the ability of cyPG to modify GFAP in cells. For this, we first used the astrocytoma cell line U-373 MG, which expresses GFAP. Incubation of U-373 MG astrocytoma cells with 15d-PGJ 2 -B resulted in the incorporation of the biotinylated cyPG into multiple polypeptides ( Fig. 2A) . Thus, a pull-down on Neutravidin beads was carried out in order to retain biotin-containing proteins. This showed the selective retention of GFAP from samples of cells treated with the biotinylated cyPG (Fig. 2B ). However, under the stringent conditions used, the retention of biotinylated proteins was not quantitative, for which the amount of GFAP retained could represent an underestimation of the amount of protein modified. The presence of vimentin and actin in the fraction retained on avidin was also observed by this method, suggesting that they are potential targets of cyPG in this cell type.
In order to assess the site of modification of GFAP in cells, U-373 MG cells were transfected with GFP-GFAP wild type (wt) and C294S constructs and treated with 15d-PGJ 2 -B. GFAP constructs were then immunoprecipitated using GFP-Trap®, which showed the specific incorporation of the biotinylated cyPG into the wild type but not into the C294S mutant construct, thus showing that C294 of GFAP is the main site for 15d-PGJ 2 -B addition in cells (Fig. 2C ).
Effects of electrophilic agents on GFAP distribution
The effects of electrophilic agents on the GFAP filament network were first explored in U-373 MG astrocytes. Treatment with 15d-PGJ 2 resulted in an intense reorganization of GFAP filaments, with a of the non-biotinylated PG for 2 h at r.t. (E) GFAP was preincubated in the dark with 10 mM iodoacetamide (Iac), followed by incubation with biotinylated cyPG at 5 µM for 2 h at r.t. The HRP-Streptavidin signals in D and E were quantitated by image scanning. Graphs depict mean values from at least three independent assays ± SEM. Results were compared by unpaired Student's t-test **p < 0.001, *p < 0.01. retraction from the cell periphery and concentration in thick bundles in the proximity of the cell nucleus (Fig. 3A) . This was highlighted by staining of f-actin, which did not suffer this drastic reorganization but persisted at the cell periphery, although it showed a loss of intensity at the central area of the cell. The marked GFAP reorganization could also be observed in cells transfected with GFP-GFAP, either live or after fixation and f-actin staining (Fig. 3B) . Consistent with the above observations, PGA 1 also induced a marked redistribution of GFAP towards the center of the cell (Fig. 3C) . To confirm the importance of the reactivity of these PG in GFAP reorganization we used 9,10-dihydro-PGJ 2 , a 15d-PGJ 2 analog that lacks the endocyclic double bond. In this analog, C9 is non-electrophilic, which greatly reduces the capacity of this compound to form covalent adducts with proteins [37] . As observed in Fig. 3C, 9 ,10-dihydro-PGJ 2 did not alter GFAP organization, thus supporting the importance of protein adduct formation for the remodeling of GFAP network. The intensity of this remodeling was quantitated as the proportion of the cellular area covered by GFAP with respect to that covered by actin filaments (Fig. 3C, lower graph) . This clearly showed the retraction of GFAP filaments in response to cyPG. Remarkably, alterations in GFAP organization did not seem to correlate with significant changes in protein levels (Fig. 3D) . Treatment of primary murine astrocytes with 15d-PGJ 2 or PGA 1 also elicited a marked redistribution of GFAP towards the perinuclear area, whereas the less electrophilic 9,10-dihydro-PGJ 2 was without effect (Fig. 4A) . The histogram depicts the degree of GFAP retraction in the total cell population, in which, at least 30% of the cells suffered a retraction of the GFAP network of more than 50%. Levels of GFAP showed a trend towards a lower abundance in cells treated with PGA 1 or 9,10-dihydro-PGJ 2 , although these changes were not statistically significant (Fig. 4B) . Vimentin levels were not affected by the agents used in either system. For this, we first used SW13/cl.2 adrenocarcinoma cells, which do not express cytoplasmic intermediate filaments [34] . As an initial approach we transfected these cells with GFP-GFAP constructs. We had previously observed that the presence of the GFP tag hampered the assembly of vimentin into full filaments in this cell type, leading to the formation of squiggles or short filaments [30] . Interestingly, in the case of GFAP, this hindrance was even more severe as both, GFP-GFAP wt and C294S constructs yielded a diffuse pattern with occasional bright dots and did not form filaments (Fig. 5A ). This distribution did not change after stable transfection (see below in Fig. 8 ). To circumvent this limitation we employed two different strategies. First, cells were transfected with untagged plasmids and the distribution of GFAP wt and C294S was assessed by immunofluorescence (Fig. 5B) . This showed the formation of robust, long filaments in the case of GFAP wt, whereas the mutant remained diffuse or, in a lower proportion of cells, in the form of small aggregates (Fig. 5B, inset) . Transfection of an untagged GFAP C294A mutant also resulted in a diffuse distribution (Fig. 5B) . Similarly, treatment of cells with a general cysteine alkylating agent, namely iodoacetamide, disrupted GFAP wt filaments leading to a mixed pattern containing both amorphous accumulations and diffuse protein (Fig. 5B) . Secondly, we transiently co-transfected cells with untagged GFAP wt or C294S plus a small amount of the corresponding GFP-GFAP constructs in order to monitor GFAP filaments in live cells (Fig. 5C ). This revealed the formation of an extended, regular GFAP network in the case of the wild type. In contrast, the C294S constructs did not form a network but only aggregates or short filaments. All these strategies show that, in the absence of other cytoplasmic intermediate filaments, the integrity of C294 of GFAP is required for network assembly in this cell type. This requirement appears to be more severe for GFAP than for vimentin organization, since both untagged vimentin wt and C328S mutant achieve filament formation in stably transfected SW13/Cl.2 cells [30] .
Remarkably, treatment of SW13/cl.2 cells expressing GFAP plus GFP-GFAP wt with 15d-PGJ 2 led to marked network reorganization with the formation of curly bundles or rings of GFAP (Fig. 5C , left panels). In contrast, 15d-PGJ 2 did not appreciably change the already anomalous distribution of GFAP C294S (Fig. 5C, right panels) . The importance of the electrophilic nature and thiol reactivity of 15d-PGJ 2 in the disruption of GFAP filaments was also supported by the fact that addition of an excess DTT during cell treatment with 15d-PGJ 2 attenuated its effect ( Fig. 5D ; please compare with Fig. 5C, left panels) .
3.5. C294 of GFAP is required for efficient self-assembly in primary astrocytes deficient in GFAP and vimentin and for reorganization in response to 15d-PGJ 2
Cysteine residues are important players in redox and electrophilic signal transduction. The fact that mutation of the single cysteine Fig. 3 residue of GFAP impairs normal filament assembly supports the notion that posttranslational modification of this residue may have deep consequences for GFAP organization in physiology and/or pathophysiology. For this reason, we set out to explore its importance in a more physiological model, namely, primary astrocytes from GFAP -/-Vim -/-mice (GV astrocytes) [5, 38] . In these cells we used the various transfection strategies detailed in Fig. 5 . Consistent with the observations in SW13/cl.2 cells, transient transfection of GV astrocytes with the GFP-GFAP fusion constructs alone did not result in filament formation (Fig. 6A) . Nevertheless, transfection of either GFAP expression vector, the bicistronic RFP//GFAP wt vector or a combination of GFAP or RFP//GFAP wt plus GFP-GFAP wt yielded an extended and robust GFAP filament network. In sharp contrast, GFAP C294S did not achieve the formation of a normal network by any of these strategies, although some filamentous structures could be occasionally observed ( Fig. 6B  and C) . Therefore, we decided to explore whether GFAP-C294S could eventually form filaments in the long term. Thus, we transfected GV astrocytes with either RFP//GFAP wt or C294S and assessed the presence of filaments at various times after transfection. In RFP//GFAP wttransfected cells, filaments could be detected as soon as 12 h after transfection, and after 24 h an extended network was apparent (Fig. 6D) . Moreover, cells with wide and homogeneous networks could be detected even 6 days after transfection. Remarkably, in the case of GFAP C294S, network formation was severely delayed, since only at the latest time point (6 days), it was possible to detect scarce cells bearing filamentous arrays (Fig. 6D) . This shows that cysteine-deficient GFAP network architecture is severely impaired or delayed in GV astrocytes, thus confirming the importance of this residue for GFAP self-organization.
Given the fact that some GFAP C294S filamentous structures could be observed after several days of expression of this construct, we used these conditions to assess their susceptibility to disruption by 15d-PGJ 2 . Our results show that whereas GFAP wt filaments suffered a severe condensation at the center of the cell upon 15d-PGJ 2 exposure, the GFAP C294S network, once formed, maintained its extended distribution after treatment with the cyPG (Fig. 6E) . Therefore, these results indicate that C294 plays a key role in the reorganization of the GFAP network induced by 15d-PGJ 2 .
Involvement of cysteine residues in GFAP-vimentin interaction
The above results have allowed us to establish that the presence of C294 is important not only for the remodeling of a GFAP-based network in response to electrophilic stress but, more significantly, for a basic process such as its initial organization. Nevertheless, in mature astrocytes, GFAP is believed not to form a network on its own but copolymerizing with other intermediate filaments, mainly vimentin [38] . Therefore, we explored the involvement of the single cysteine residues of these two proteins in GFAP-vimentin heterooligomerization. For this, we first set in vitro homo or heteroligomerization assays followed by crosslinking with the cysteine bifunctional reagent dibromobimane (DBB), which is intended to crosslink spatially vicinal cysteines (spacer arm, 4.88 Å). Incubation of either GFAP or vimentin with DBB in vitro resulted in the formation of oligomeric species of electrophoretic mobility of approximately 140 kDa and 150 kDa, in the case of GFAP, and 160 kDa in the case of vimentin, in denaturing SDS-PAGE (Fig. 7A) , which are compatible with the formation of dimers of each protein [30, 39] . In both cases, crosslinking of proteins preincubated with NaCl was more efficient, suggesting that the cysteine residues are more prone to interaction in the polymerized proteins. Interestingly, incubation of mixtures containing both GFAP and vimentin with DBB induced the appearance of a band not present in the incubations of either protein alone (marked by an arrow in Fig. 7A ). This additional band, which showed an electrophoretic mobility in between that of GFAP and vimentin homodimers, was recognized by antibodies against GFAP and vimentin, and likely represents a heterodimer of both proteins (Fig. 7A , middle panels). To better illustrate this point, the densitometric profile of the oligomers detected with either antibody is shown on the right. Therefore, these results indicate that under these conditions, at least some of the cysteine residues of both proteins present in the filaments can be at a close distance, thus participating in their interaction. Nevertheless, the precise nature of this interaction, that is, whether it takes place between different native dimers, tetramers or even filaments, cannot be deduced from our results.
Next, we monitored the formation of GFAP-vimentin crosslinks in intact cells (Fig. 7B ). For this, U-373 MG astrocytoma cells were incubated in the presence of DBB and the electrophoretic mobility of GFAP and vimentin was assessed. Both, GFAP and vimentin formed oligomeric species in the presence of DBB that were resistant to denaturing conditions. Of these, several signals of electrophoretic mobility close to 150 kDa, were compatible with the formation of cysteinecrosslinked dimers. Remarkably, one of these bands showed immunoreactivity with both, anti-vimentin and anti-GFAP antibodies, suggesting that it could represent a heterooligomer of both proteins (marked by arrows in Fig. 7B and quantitated in the profile in the right panel). In addition, several higher molecular weight species were observed that did not appear to be recognized by both antibodies. To further substantiate the nature of the putative GFAP-vimentin crosslinking product we performed immunoprecipitation of the U-373 MG lysates with anti-vimentin antibody (Fig. 7C) . Noticeably, the anti-vimentin antibody efficiently immunoprecipitated both vimentin and GFAP monomers. This is consistent with the participation of these proteins in closely related structures. Moreover, vimentin immunoprecipitation efficiently enriched oligomeric species, among which, the 150 kDa band positive for both, GFAP and vimentin, indicative of the putative heterooligomer, was clearly detected. Thus, the appearance of DBB-crosslinked species reactive with both vimentin and GFAP antibodies in intact cells supports that there are cysteine residues located in close range in the native networks.
Importance of C294 in GFAP-vimentin network formation
To assess the functional importance of the cysteine residues in the formation of GFAP-vimentin hybrid networks we first used SW13/cl.2 cells. These cells were transfected with wild type or cysteine to serine mutants of GFAP and/or vimentin constructs, in different combinations, according to the scheme shown in Fig. 8A , upper panel. Thus, cells stably transfected with RFP//vimentin wt or C328S, both of which possess an extended untagged vimentin network and the characteristic red background [30] , were transiently transfected with GFP-GFAP wt or C294S, which, as shown in Fig. 5 , cannot form filaments on their own. Remarkably, combination of the wt proteins allowed the visualization of a homogeneous fluorescent network, meaning that GFP-GFAP wt was efficiently incorporated into vimentin wt filaments (Fig. 8B, left) . In contrast, combination of the cysteine to serine mutants of both proteins yielded only bright aggregates or incipient filaments depending on the levels of GFP-GFAP C294S, thus showing a defective organization of the network when the two cysteine-deficient mutants are used (Fig. 8B,  right) . More importantly, as stably transfected vimentin C328S forms an extended network, the formation of aggregates upon transfection of GFP-GFAP C294S implies that this mutant disturbs the preexisting vimentin filaments. This could be confirmed by immunofluorescence of vimentin (Fig. 8B, lower panels) , which showed disruption of vimentin filaments in cells expressing GFP-GFAP C294S, but preservation in cells that did not result transfected this construct.
We next performed the reciprocal experiment, as depicted in the scheme of Fig. 8A , lower panel. Therefore, SW13/cl.2 cells stably transfected with GFP-GFAP wt or GFP-GFAP C294S, in which both GFAP constructs adopt a diffuse distribution, were transiently transfected with the bicistronic plasmids RFP//vimentin wt or C328S mutant (Fig. 8C) . Interestingly, diffuse GFP-GFAP wt was effectively recruited onto filaments only in cells transfected with untagged vimentin wt (indicated by the red background). In contrast, formation of filaments was less efficient in cells expressing the cysteine to serine mutants, in such a way that GFP-GFAP C294S distributed in dots or formed an incomplete network. Thus, formation of hybrid GFAP-vimentin networks of normal appearance by combination of these constructs requires the presence of the cysteine residues both in vimentin and GFAP.
In view of these results we set out to confirm the importance of cysteine residues in the assembly of a vimentin-GFAP network in a more physiological context. For this we compared the patterns of the wild type and cysteine to serine mutants of each protein alone and in combination after transient transfection in GV astrocytes (Fig. 9) . We had shown above that in this cell type the formation of filaments by the GFAP C294S mutant was severely delayed with respect to the wild type (Fig. 6B) , with filaments of normal appearance being observed only at the latest time-point after transfection (six days). In contrast, transfection of either vimentin wild type or C328S resulted in the formation of long filaments from the earliest time point monitored (12 h, Fig. 9A ). These observations confirm that GFAP is more dependent than vimentin on the presence of the single cysteine residue for filament formation. Next, we assessed the structures formed by GFAP and vimentin together (Fig. 9B) . Transfection of a mixture of the wild type proteins allowed detection of extended filaments at all time points. Conversely, combination of the cysteine to serine mutants resulted in defective network formation at the earlier time points, with wide areas of the cell cytoplasm showing a diffuse GFAP C294S distribution, as well as a poorer organization of vimentin (12 h), or poorly-defined GFAP C294S filaments (24 h ). This is corroborated by the fluorescence intensity profiles along the indicated sections of the cells (dotted lines), which show a clear overlap of vimentin and GFAP signals for the wild type proteins, but a defective overlap for the mutant proteins at the early time points. At the later time points, more GFAP C294S was recruited onto filaments, as illustrated by the coincidence of the fluorescence intensity profiles of vimentin and GFAP, which resulted in the formation of more regular hybrid networks in approximately 35% of the cells after six days. Individual channels for these images are provided in Supplementary material Fig. 1 .
Remarkably, the deleterious effect of the mutation of the cysteine residues on the formation of a GFAP-vimentin network was even more intense when the GFP-tagged version of the GFAP C294S construct was used (Fig. 9C) . Thus, whereas GFP-GFAP wt efficiently co-polymerized with vimentin, GFP-GFAP C294S formed aggregates which also trapped vimentin (Fig. 9C) , showing that the presence of mutant GFAP exerted a deleterious effect on vimentin organization. These aggregates persisted at least 48 h, a time at which some vimentin filaments could be detected surrounding GFAP accumulations (inset). At 6 days, GFP-GFAP C294S was also incorporated into vimentin filaments. Individual channels for these images are shown in Supplementary material Fig. 2 . Taken together, these results clearly show that hybrid network formation is delayed upon transfection of GV astrocytes with cysteine to serine mutants of GFAP and vimentin compared with the wild type proteins. Moreover, whereas GFAP C294S appears to hamper the formation of filaments by vimentin, above all at early time-points, vimentin seems to exert the opposite effect, facilitating network formation in the presence of mutant GFAP (compare Figs. 6B and 9B) . 
Discussion
The results herein described clearly show that the single cysteine residue of the type III intermediate protein GFAP is a target for modification and remodeling in response to electrophilic mediators. More importantly, they demonstrate that this residue is necessary for the appropriate organization of GFAP and its co-polymerization with vimentin. These observations put forward a potential role of modifications of the single cysteine residue in pathophysiological processes associated with alterations in GFAP assembly or aggregation.
Increased lipid peroxidation is a hallmark of human aging and of diseases associated with oxidative stress, like cardiovascular or neurodegenerative diseases [40] . Electrophilic lipids of various classes generated under these conditions form adducts with proteins altering their function, in a process called lipoxidation [41] . Our results show that GFAP is a target for lipoxidation and point to its single cysteine residue as the main site for modification by cyPG. This conclusion stems from the observations that the incorporation of biotinylated cyPG is practically abolished in the GFAP C294S mutant. The importance of electrophilic cysteine modification for network reorganization is supported by the observations of the lack of effect of the less electrophilic 15d-PGJ 2 analog, 9,10-dihydro-PGJ 2 , the disrupting effect of iodoacetamide, and the attenuation of the effect of 15d-PGJ 2 by co-incubation with DTT. Yet, general cysteine reagents can obviously affect multiple targets. Notably, cyPG can also act through multiple mechanisms. CyPG directly adduct to proteins but they can also be potent inducers oxidative stress [42, 43] , which in turn can cause "indirect" protein modifications such as thiolation [44] or other types of oxidation. These oxidative modifications could also contribute to the reorganization of GFAP wt. In addition, by modifying redox-sensitive enzymes, like deacetylases or phosphatases, cyPG can influence other posttranslational modifications such as phosphorylation or acetylation [45, 46] . Moreover, cyPG and 9,10-dihydro-PGJ 2 can act as agonists of PPAR [35, 37] , which has been involved in the regulation of GFAP expression [47] . Nevertheless, the fact that the C294S mutant is resistant to the drastic rearrangement of GFAP network induced by electrophilic lipids indicates that the mechanisms responsible occur at the protein level and that modification of C294 is critical for this effect.
Oxidative stress is a well-recognized pathogenic factor in brain injury and neurodegenerative diseases [48, 49] , for which antioxidant compounds and potentiation of antioxidant defenses have been proposed as potential therapeutic strategies [50] . Remarkably, whereas the increased expression of GFAP in response to injury, including oxidative damage is well characterized [51] , morphological studies demonstrating changes in network organization are scarcer. Previous redox proteomics studies have identified GFAP as a target for oxidation in certain pathophysiological situations. Increased carbonylation of GFAP has been reported in the frontal cortex of subjects with Down Syndrome compared to age-matched controls [52] and in aceruloplasminemia [53] , a disease characterized by intracellular iron overload and oxidative stress. Also, increased GFAP immunoreactivity towards antibodies against advanced glycation products has been detected in palsy-like pathology [54] . However, the residues involved and the precise functional consequences of the modifications have not been identified. Thus, to the best of our knowledge, our study provides the first structural-functional evidence of the effect of electrophilic stress on GFAP organization focusing on specific residues. As far as we know, mutations at C294 of GFAP have not been identified in nature. Nevertheless, in Alexander disease, GFAP mutations often resulting in a change for a more nucleophilic amino acid, impair assembly, induce formation of aggregates called Rosenthal fibers, oxidative stress, activation of stress cascades and production of inflammatory mediators that promote neurodegeneration [10, 55, 56] . Interestingly, besides approaches aimed at reducing GFAP levels, some antioxidant strategies have resulted in beneficial effects in models of Alexander disease [57] . Thus, in light of the results herein reported, direct oxidative damage of GFAP C294 could potentially contribute to amplify the deleterious mechanisms of this disease. Moreover, the potential implications of modifications of vimentin, the GFAP co-polymerization partner in astrocytes, deserve further studies.
The high conservation of C294, or its equivalent residues, in the different type III intermediate filaments as well as across species, underscores its functional significance. Remarkably, the attempts to express the GFAP C294S mutant in cells have unveiled the importance of this residue for GFAP assembly and network formation. Whereas GFAP wt is able to form extended networks when transfected in several cell types, including cytoplasmic intermediate filament-deficient SW13/cl.2 cells and GV primary astrocytes, GFAP C294S shows a null or much more limited ability to assemble in filaments. This impairment is even more intense when additional impediments, like a GFP tag, are introduced. The requirement for the cysteine residue appears to be more stringent in GFAP than in vimentin. Thus, GFAP C294S does not form filaments in conditions under which vimentin C328S does. GFAP and vimentin are highly homologous proteins, sharing 58% identity, with the main differences located in the amino-terminal domain, which is essential for assembly [58, 59] . It is tempting to speculate that these differences could determine a higher susceptibility to the impact of modifications of the cysteine residue. Importantly, cysteine residues from both GFAP and vimentin are also required for the formation of hybrid networks. In SW13/cl.2 cells, GFP-GFAP wt is able to incorporate into vimentin filaments, but co-polymerization of the C294S mutant is hampered and it even disrupts the vimentin network. Furthermore, in GV astrocytes, the wild type proteins give rise to hybrid networks shortly after transfection. However, this process is delayed in the case of the cysteine to serine mutants. Moreover, in this cell type, GFAP and vimentin behave differently: mutant GFAP has a negative impact on the formation of the network, whereas vimentin seems to exert a positive effect on the organization of mutant GFAP. In this regard, it can be mentioned that anomalous organization of GFAP, with reduced space between individual filaments, has been previously noted in astrocytes from vimentin-null mice, indicating that vimentin could play a facilitating role for GFAP organization [38] .
Insight into the potential causes of the behavior of the mutant proteins was obtained from experiments in vitro and in U-373 MG astrocytoma cells. Crosslinking of the purified proteins with the bifunctional cysteine reagent DBB induced the appearance of oligomeric species compatible with dimers. These results are consistent with early studies provoking the oxidative crosslinking of vimentin and GFAP present in isolated cytoskeletal fractions [60] . Moreover, we could also detect a GFAP-vimentin complex after crosslinking in live cells. Although the biochemical conformation and origin of this dimer could not be ascertained, our observations suggest that the cysteine residues are Fig. 9 . Importance of cysteine residues for the formation of a GFAP-vimentin network in GV astrocytes. GV astrocytes were transfected with plasmids coding for GFAP and vimentin wt or the cysteine to serine mutants, as indicated, and the distribution of both proteins was assessed by immunofluorescence at increasing times after transfection. spatially close in filaments and contribute, directly or indirectly to the assembly and/or stability of the network. However, this does not imply that vimentin and GFAP assemble in hybrid dimers, but possibly reflects an interaction between monomers located in neighboring tetramers or even adjacent filament precursors or ULF. Indeed, the spatial organization and stoichiometry of GFAP and vimentin in astrocyte intermediate filaments has not been completely elucidated. Interestingly, recent evidence from immunofluorescence and superresolution microscopy obtained in U-373 MG astrocytoma cells indicates that the organization of the two proteins, together with nestin, is not uniform along the length of the filament, and that they are present in variable proportions in different filament stretches [61] . Thus the possibilities of interaction between GFAP and vimentin will be multiple.
Conclusion
In summary, our findings define a key role of the conserved cysteine residue on type III intermediate filaments in mediating the response of the network to oxidized lipids. Moreover, this residue appears to play a central role in the organization or assembly of the filaments. Interestingly, the requirement for the presence of the single cysteine is more stringent in GFAP than in vimentin when assembling on their own. Nonetheless, the presence of the cysteine residue is important for vimentin-GFAP heteropolymerization. Likewise, whereas mutant GFAP is deleterious for network formation, vimentin seems to play a facilitating role for the assembly of mutant GFAP. The importance of this residue in assembly and its role as a critical sensor for stress and mediator of GFAP remodeling, support its involvement in the pathophysiology of neurological diseases associated with oxidative stress and disruption of GFAP organization.
